近10年来,随着分子生物学的深入研究和大型临床试验的广泛开展,逐渐有学者提出应用急性肾损伤(a-cutekidneyinjury,AKI)来取代传统急性肾衰竭(ARF)的概念。目前认识到,在致病因子作用下有些患者虽已发生不同程度的急性肾功能异常,但还未进入肾衰竭阶段,故把“衰竭(failure)”改 In the recent 10 years, along with the extensive research in molecular biology and the extensive clinical trials, scholars gradually proposed the concept of using acute renal injury (AKI) instead of traditional acute renal failure (ARF). At present, it is recognized that although some patients have some degree of acute renal dysfunction under the action of pathogenic factors, they have not yet entered the stage of renal failure. Therefore, “failure”